CVE:PDP - Pediapharm Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
C$0.33 0.00 (0.00 %)
(As of 05/21/2018 03:20 AM ET)
Previous CloseC$0.33
Today's RangeC$0.33 - C$0.33
52-Week RangeC$0.25 - C$0.34
Volume5,600 shs
Average Volume113,950 shs
Market CapitalizationC$28.85 million
P/E RatioN/A
Dividend YieldN/A

About Pediapharm (CVE:PDP)

Pediapharm Inc. operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children. The company's product portfolio includes NYDA, a product for the treatment of head lice and its eggs; Relaxa to treat constipation; and naproxen suspension to treat medical pain conditions in Juvenile Arthritis. It also offers Rupatadine to treat the symptoms of allergy and urticarial; Otixal for ear infection; and Cuvposa to treat severe drooling and cerebral palsy. The company also provides marketing services related to pediatric care. Pediapharm Inc. is headquartered in Verdun, Canada.

Receive PDP News and Ratings via Email

Sign-up to receive the latest news and ratings for PDP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-10.92%
Return on Equity-26.38%
Return on Assets-11.84%


Outstanding Shares87,415,000

Pediapharm (CVE:PDP) Frequently Asked Questions

What is Pediapharm's stock symbol?

Pediapharm trades on the Canadian Venture Exchange (CVE) under the ticker symbol "PDP."

How were Pediapharm's earnings last quarter?

Pediapharm (CVE:PDP) announced its quarterly earnings results on Tuesday, February, 27th. The company reported ($0.01) EPS for the quarter, meeting the Zacks' consensus estimate of ($0.01). The company earned $2.36 million during the quarter, compared to analysts' expectations of $2.60 million. Pediapharm had a negative return on equity of 26.38% and a negative net margin of 10.92%. View Pediapharm's Earnings History.

When is Pediapharm's next earnings date?

Pediapharm is scheduled to release their next quarterly earnings announcement on Wednesday, June, 27th 2018. View Earnings Estimates for Pediapharm.

Who are some of Pediapharm's key competitors?

Who are Pediapharm's key executives?

Pediapharm's management team includes the folowing people:
  • Mr. Sylvain Chretien, Pres, CEO & Director (Age 54)
  • Roland Boivin, Chief Financial Officer
  • Mr. Richard Labelle, VP of Sales & Marketing
  • Mr. Benoît Hébert, VP of Bus. Devel. & Licensing (Age 50)

Has Pediapharm been receiving favorable news coverage?

News stories about PDP stock have been trending somewhat positive recently, Accern reports. The research group scores the sentiment of press coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Pediapharm earned a news sentiment score of 0.06 on Accern's scale. They also gave news articles about the company an impact score of 47.11 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

How do I buy shares of Pediapharm?

Shares of PDP and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Pediapharm's stock price today?

One share of PDP stock can currently be purchased for approximately C$0.33.

How big of a company is Pediapharm?

Pediapharm has a market capitalization of C$28.85 million.

How can I contact Pediapharm?

Pediapharm's mailing address is 1 du Commerce Pl Suite 225, VERDUN, QC H3E 1A2, Canada. The company can be reached via phone at +1-514-7622626.

MarketBeat Community Rating for Pediapharm (PDP)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  21 (Vote Outperform)
Underperform Votes:  20 (Vote Underperform)
Total Votes:  41
MarketBeat's community ratings are surveys of what our community members think about Pediapharm and other stocks. Vote "Outperform" if you believe PDP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PDP will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Pediapharm (CVE:PDP) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
(Data available from 5/21/2016 forward)


Pediapharm (CVE:PDP) Earnings History and Estimates Chart

Earnings by Quarter for Pediapharm (CVE:PDP)

Pediapharm (CVE PDP) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/27/2018Q3 2018C($0.01)C($0.01)C$2.60 millionC$2.36 millionViewN/AView Earnings Details
8/24/2017Q1 2018C($0.01)C($0.01)C$2.00 millionC$2.47 millionViewN/AView Earnings Details
6/28/2017Q4 2017C($0.02)C($0.02)C$1.50 millionC$1.66 millionViewN/AView Earnings Details
2/28/2017Q3 2017C($0.01)C($0.01)C$1.77 millionViewN/AView Earnings Details
11/28/2016Q2 2017C($0.01)C$1.88 millionViewN/AView Earnings Details
8/18/2016Q1 2017C$0.02C$0.89 millionViewN/AView Earnings Details
6/27/2016Q4 2016C($0.02)C$0.65 millionViewN/AView Earnings Details
2/25/2016Q3 2016C($0.02)C$1.02 millionViewN/AView Earnings Details
11/30/2015Q2 2016C($0.01)C$1.47 millionViewN/AView Earnings Details
8/27/2015Q1 2016C($0.02)C$0.61 millionViewN/AView Earnings Details
7/20/2015Q4 2015C($0.03)C$0.34 millionViewN/AView Earnings Details
3/2/2015Q3 2015C($0.02)C$0.92 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Pediapharm (CVE:PDP) Dividend Information

Pediapharm pays an annual dividend of C$0.14 per share, with a dividend yield of 42.42%.
Annual Dividend:$0.14
Dividend Yield:42.42%
Payout Ratio(s):N/A
Dividend Payments by Quarter for Pediapharm (CVE:PDP)

Pediapharm (CVE:PDP) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Pediapharm (CVE PDP) Insider Trading and Institutional Ownership History

Insider Trading History for Pediapharm (CVE:PDP)

Pediapharm (CVE PDP) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)


Pediapharm (CVE PDP) News Headlines

Pediapharm Announces the Commercial Launch of Cuvposa™ in CanadaPediapharm Announces the Commercial Launch of Cuvposa™ in Canada - April 3 at 10:49 AM
Pediapharm Inc. (PDP) Scheduled to Post Earnings on WednesdayPediapharm Inc. (PDP) Scheduled to Post Earnings on Wednesday - August 9 at 7:22 AM

SEC Filings

Pediapharm (CVE:PDP) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Financials are not available for this stock.


Pediapharm (CVE PDP) Stock Chart for Monday, May, 21, 2018

Loading chart…

This page was last updated on 5/21/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.